31 results - M - W - D

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

8/4/05 17:53
8/2/05
AGNTHealthDiagnIn Vitro & In Vivo DiagnosticHusic Frank J & CoCATS.m-60.26270-21-1000I
8/4/05 17:41
8/2/05
AGNTHealthDiagnIn Vitro & In Vivo DiagnosticHusic Frank JCATS.m-5600.26270-2,132-1000I
8/4/05 17:30
8/2/05
AGNTHealthDiagnIn Vitro & In Vivo DiagnosticHusic Capital ManagementCATS.m-5600.26270-2,132-1000D
8/1/05 17:32
7/29/05
AGNTHealthDiagnIn Vitro & In Vivo DiagnosticHusic Frank J & CoCATS.m-20.26940-7-2521I
8/1/05 17:20
7/29/05
AGNTHealthDiagnIn Vitro & In Vivo DiagnosticHusic Frank JCATS.m-1890.26940-700-252,132I
8/1/05 17:05
7/29/05
AGNTHealthDiagnIn Vitro & In Vivo DiagnosticHusic Capital ManagementCATS.m-1890.26940-700-252,132D
6/17/05 14:35
6/15/05
AGNTHealthDiagnIn Vitro & In Vivo DiagnosticGoldenstein Lissa ACAHFormer PM.d400.850004774111D
6/10/05 18:39
6/9/05
AGNTHealthDiagnIn Vitro & In Vivo DiagnosticLabadie Jeffrey WCAOSVP,ChemM.d180.85000218445D
6/10/05 18:39
6/9/05
AGNTHealthDiagnIn Vitro & In Vivo DiagnosticLabadie Jeffrey WCAOSVP,ChemS.d-200.99000-21-3145D
6/2/05 17:48
6/2/05
AGNTHealthDiagnIn Vitro & In Vivo DiagnosticBentovim Lyron LCADP5380.96840556203,294I
5/19/05 19:16
5/18/05
AGNTHealthDiagnIn Vitro & In Vivo DiagnosticLabadie Jeffrey WCAOSVP,ChemM.d220.647603533045D
5/19/05 19:16
5/18/05
AGNTHealthDiagnIn Vitro & In Vivo DiagnosticLabadie Jeffrey WCAOSVP,ChemS.d-330.93000-35-4445D
4/7/05 14:47
3/14/05
AGNTHealthDiagnIn Vitro & In Vivo DiagnosticHusic Frank J & CoCATS.m00.877200028I
4/7/05 14:26
3/14/05
AGNTHealthDiagnIn Vitro & In Vivo DiagnosticHusic Frank JCATS.m-90.87790-1002,832I
4/7/05 13:51
3/14/05
AGNTHealthDiagnIn Vitro & In Vivo DiagnosticHusic Capital ManagementCATS.m-90.87790-1002,832D
2/25/05 14:10
2/24/05
AGNTHealthDiagnIn Vitro & In Vivo DiagnosticHusic Frank J & CoCATS-10.76930-1-428I
2/25/05 14:02
2/24/05
AGNTHealthDiagnIn Vitro & In Vivo DiagnosticHusic Frank JTS-950.76930-123-42,842I
2/25/05 13:54
2/24/05
AGNTHealthDiagnIn Vitro & In Vivo DiagnosticHusic Capital ManagementCATS-950.76930-123-42,842D
2/24/05 16:42
2/23/05
AGNTHealthDiagnIn Vitro & In Vivo DiagnosticHusic Frank JTS-1180.78990-150-52,965I
2/24/05 16:33
2/23/05
AGNTHealthDiagnIn Vitro & In Vivo DiagnosticHusic Frank J & CoCATS-10.78990-2-530I
2/24/05 16:24
2/23/05
AGNTHealthDiagnIn Vitro & In Vivo DiagnosticHusic Capital ManagementCATS-1180.78990-150-52,965D
2/24/05 14:15
2/22/05
AGNTHealthDiagnIn Vitro & In Vivo DiagnosticHusic Frank J & CoCATS-10.80750-1-331I
2/24/05 14:02
2/22/05
AGNTHealthDiagnIn Vitro & In Vivo DiagnosticHusic Frank JCATS-810.80750-100-33,115I
2/24/05 13:47
2/22/05
AGNTHealthDiagnIn Vitro & In Vivo DiagnosticHusic Capital ManagementCATS-810.80750-100-33,115D
10/12/04 13:54
10/11/04
AGNTHealthDiagnIn Vitro & In Vivo DiagnosticHusic Capital ManagementCATS-110.89250-1205,007D
10/12/04 13:31
10/11/04
AGNTHealthDiagnIn Vitro & In Vivo DiagnosticHusic Frank J & CoCATS00.892500050I
10/12/04 13:30
10/11/04
AGNTHealthDiagnIn Vitro & In Vivo DiagnosticHusic Frank JCADTS-110.89250-1205,007I
3/2/04 21:30
2/27/04
AGNTHealthDiagnIn Vitro & In Vivo DiagnosticLabadie Jeffrey WCAOVP ChemiS-211.520-14-3822D
12/12/03 18:08
12/10/03
AGNTHealthDiagnIn Vitro & In Vivo DiagnosticGoldenstein Lissa ACADOP,CEOM.d150.56800267064D
12/3/03 14:29
12/2/03
AGNTHealthDiagnIn Vitro & In Vivo DiagnosticGoldstein HowardCAOSVP,SaleP.d71.39053320D
11/10/03 20:06
11/7/03
AGNTHealthDiagnIn Vitro & In Vivo DiagnosticFoster David JCAOCFOP.d121.2001020015D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact